Trial Profile
A phase IIb trial of YKP 3089 for the treatment of neuropathic pain
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Mar 2012
Price :
$35
*
At a glance
- Drugs Cenobamate (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 06 Mar 2012 New trial record